"Calcitriol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.
| Descriptor ID |
D002117
|
| MeSH Number(s) |
D04.210.500.247.222.159.478.387.300 D04.210.500.247.808.146.478.387.300 D04.210.500.812.768.196.478.387.300 D10.570.938.146.478.387.300
|
| Concept/Terms |
Calcitriol- Calcitriol
- 1 alpha,25-Dihydroxyvitamin D3
- 1 alpha,25 Dihydroxyvitamin D3
- D3, 1 alpha,25-Dihydroxyvitamin
- alpha,25-Dihydroxyvitamin D3, 1
- 1,25-Dihydroxyvitamin D3
- 1,25 Dihydroxyvitamin D3
- D3, 1,25-Dihydroxyvitamin
- 1 alpha,25-Dihydroxycholecalciferol
- 1 alpha,25 Dihydroxycholecalciferol
- 1,25-Dihydroxycholecalciferol
- 1,25 Dihydroxycholecalciferol
20-epi-1alpha,25-dihydroxycholecaliferol- 20-epi-1alpha,25-dihydroxycholecaliferol
- 20 epi 1alpha,25 dihydroxycholecaliferol
- 1,25-dihydroxy-20-epi-Vitamin D3
- 1,25 dihydroxy 20 epi Vitamin D3
- D3, 1,25-dihydroxy-20-epi-Vitamin
- 1,25(OH)2-20epi-D3
- 1 alpha, 25-dihydroxy-20-epi-Vitamin D3
- 1 alpha, 25 dihydroxy 20 epi Vitamin D3
|
Below are MeSH descriptors whose meaning is more general than "Calcitriol".
Below are MeSH descriptors whose meaning is more specific than "Calcitriol".
This graph shows the total number of publications written about "Calcitriol" by people in this website by year, and whether "Calcitriol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 1 | 4 | 5 |
| 2006 | 0 | 2 | 2 |
| 2007 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 3 | 4 |
| 2011 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 2 | 2 | 4 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcitriol" by people in Profiles.
-
Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi expert panel recommendations from ITSCC. J Am Acad Dermatol. 2026 Jul; 95(1):112-120.
-
Extracellular Vesicles of Commensal Skin Microbiota Alleviate Cutaneous Inflammation in Atopic Dermatitis Mouse Model by Re-Establishing Skin Homeostasis. J Invest Dermatol. 2025 02; 145(2):312-322.e9.
-
Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol Genomics. 2021 11 01; 53(11):486-508.
-
Analysis of 1,25-Dihydroxyvitamin D3 Genomic Action Reveals Calcium-Regulating and Calcium-Independent Effects in Mouse Intestine and Human Enteroids. Mol Cell Biol. 2020 12 21; 41(1).
-
Sensitive and rapid UHPLC-MS/MS assay for simultaneous quantifications of calcipotriol and paclitaxel in rat whole blood and plasma samples. J Pharm Biomed Anal. 2021 Jan 05; 192:113685.
-
Vitamin D actions in neurons require the PI3K pathway for both enhancing insulin signaling and rapid depolarizing effects. J Steroid Biochem Mol Biol. 2020 06; 200:105690.
-
Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2. Int J Mol Sci. 2020 Mar 27; 21(7).
-
Preoperative calcitriol reduces postoperative intravenous calcium requirements and length of stay in parathyroidectomy for renal-origin hyperparathyroidism. Surgery. 2019 01; 165(1):151-157.
-
Regulation of Reduced Folate Carrier (RFC) by Vitamin D Receptor at the Blood-Brain Barrier. Mol Pharm. 2017 11 06; 14(11):3848-3858.
-
Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions. J Pediatr Hematol Oncol. 2017 01; 39(1):e21-e24.